Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30157
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | ALONSO ABAD, Ariel | - |
dc.contributor.author | VAN DER ELST, Wim | - |
dc.contributor.author | MOLENBERGHS, Geert | - |
dc.contributor.author | Florez, Alvaro J. | - |
dc.date.accessioned | 2019-12-16T13:36:45Z | - |
dc.date.available | 2019-12-16T13:36:45Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 29(3), p. 529-540 | - |
dc.identifier.uri | http://hdl.handle.net/1942/30157 | - |
dc.description.abstract | At the beginning of the 21st century, a new paradigm was introduced for the evaluation of surrogate endpoints based on meta-analysis. In this paradigm, the putative surrogate is assessed at two different levels, the so-called, trial and individual level. Trial level surrogacy is defined as the association between the expected causal treatment effects across different trials populations, whereas the individual level is defined as the association between the surrogate and true endpoints, after adjusting by trial and treatment. It has been argued that the individual level surrogacy does not have a causal interpretation and, consequently, it is a poor metric of surrogacy. In the present work, an alternative definition of individual level surrogacy is introduced based on individual causal treatment effects. In addition, using the maximum entropy principle, a direct link between the individual level surrogacy, as defined in the meta-analytic approach, and the newly proposed definition is established. This new perspective sets the individual level surrogacy in a more coherent framework with respect to the trial level and bridges the two main schools of thought in this domain, namely, the causal inference and meta-analytic schools. | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS INC | - |
dc.subject.other | Causal inference | - |
dc.subject.other | meta-analytic approach | - |
dc.subject.other | maximum entropy | - |
dc.subject.other | surrogate endpoints | - |
dc.title | A reflection on the causal interpretation of individual-level surrogacy | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 540 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 529 | - |
dc.identifier.volume | 29 | - |
local.format.pages | 12 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Alonso, Ariel; Florez, Alvaro J.] Katholieke Univ Leuven, I BioStat, Kapucijnenvoer 35, B-3000 Leuven, Belgium. [Van der Elst, Wim] Janssen Pharmaceut Co Johnson & Johnson, Quantitat Sci, Beerse, Belgium. [Molenberghs, Geert] Univ Hasselt, I BioStat, Diepenbeek, Belgium. | - |
local.publisher.place | PHILADELPHIA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1080/10543406.2019.1579221 | - |
dc.identifier.isi | 000469139500009 | - |
item.accessRights | Closed Access | - |
item.validation | ecoom 2020 | - |
item.fulltext | No Fulltext | - |
item.contributor | ALONSO ABAD, Ariel | - |
item.contributor | VAN DER ELST, Wim | - |
item.contributor | MOLENBERGHS, Geert | - |
item.contributor | Florez, Alvaro J. | - |
item.fullcitation | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert & Florez, Alvaro J. (2019) A reflection on the causal interpretation of individual-level surrogacy. In: JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 29(3), p. 529-540. | - |
crisitem.journal.issn | 1054-3406 | - |
crisitem.journal.eissn | 1520-5711 | - |
Appears in Collections: | Research publications |
WEB OF SCIENCETM
Citations
2
checked on Apr 24, 2024
Page view(s)
40
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.